1. Home
  2. Sistema de Salut de Catalunya
  3. Vall d'Hebron Hospital Universitari – HVH
  4. Articles científics - HVH
  5. View Item

Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS data

To access the full text documents, please follow this link: https://hdl.handle.net/11351/13663

Author

Cervera, Ricard

Freire-González, Mercedes

Turrión Nieves, Ana Isabel

Rua Figueroa, Iñigo

Cortes Hernandez, Josefina

Castellvi, Ivan

Other authors

Institut Català de la Salut

[Rua-Figueroa I] Rheumatology, Complejo Hospitalario Doctor Negrin, Las Palmas de Gran Canaria, Spain. [Cervera R] Hospital Clinic of Barcelona, Barcelona, Spain. [Freire-González M] Rheumatology, University Hospital Complex of A Coruña, A Coruña, Spain. [Turrión Nieves AI] Department of Rheumatology, Hospital Universitario de Salamanca, Salamanca, Spain. [Cortés-Hernández J] Servei de Reumatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Castellvi I] Department of Rheumatology, Hospital Universitari de Santa Creu i Sant Pau, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2025-09-16T11:32:54Z

2025-09-16T11:32:54Z

2025-07-22



Share

Abstract

Glucocorticoids; Lupus erythematosus systemic; Patient reported outcome measures

Glucocorticoides; Lupus eritematós sistèmic; Mesures de resultats informades pels pacients

Glucocorticoides; Lupus eritematoso sistémico; Medidas de resultados informadas por los pacientes

This analysis has been funded by AstraZeneca Farmaceutica Spain

Document Type

Article

Published version

Language

English

Subjects and keywords

Glucocorticoides - Ús terapèutic - Efectes secundaris; Lupus eritematós sistèmic - Tractament; CHEMICALS AND DRUGS::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Adrenal Cortex Hormones::Glucocorticoids; Other subheadings::Other subheadings::Other subheadings::/adverse effects; DISEASES::Skin and Connective Tissue Diseases::Connective Tissue Diseases::Lupus Erythematosus, Systemic; Other subheadings::Other subheadings::Other subheadings::/drug therapy; COMPUESTOS QUÍMICOS Y DROGAS::hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::hormonas de la corteza suprarrenal::glucocorticoides; Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos; ENFERMEDADES::enfermedades de la piel y tejido conjuntivo::enfermedades del tejido conjuntivo::lupus eritematoso sistémico; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

Publisher

BMJ

Related items

Lupus Science & Medicine;12(2)

https://doi.org/10.1136/lupus-2025-001597

Recommended citation

This citation was generated automatically.

Export

DIDL MARC MARC_CCUC METS OAI_DC ORE QDC RDF

Rights

Attribution-NonCommercial 4.0 International

http://creativecommons.org/licenses/by-nc/4.0/

This item appears in the following Collection(s)

Articles científics - HVH [3440]